Salud Mental

Impact of menstrual cycle on smoking cessation: A review

##plugins.themes.bootstrap3.article.main##

Mariana Núñez-Lauriano
Jennifer Lira-Mandujano
M. Carmen Míguez
Marcela Tiburcio

Resumen

Antecedentes. La información sobre cómo las diferentes fases del ciclo menstrual pueden influir en el logro de la abstinencia de tabaco es contradictoria.

Objetivo. Se realizó una revisión de alcance con el fin identificar la evidencia relacionada al efecto del ciclo menstrual en la abstinencia de tabaco, considerando las variables fases del ciclo, niveles hormonales y síndrome premenstrual.

Método. Se llevó a cabo una búsqueda de la literatura en las bases de datos Scopus, PubMed, MEDLINE y PsycINFO. Se incluyeron diez artículos que realizaban comparaciones entre las fases del ciclo menstrual o bien análisis entre el síndrome premenstrual y una condición de abstinencia (tiempo de abstinencia o síntomas de abstinencia).

Resultados. Se identificaron dos resultados principales 1) no hay diferencia en los síntomas de abstinencia y el deseo por fumar entre las fases del ciclo menstrual y 2) las tasas de abstinencia de los estudios fueron mayores durante la fase lútea.

Discusión y conclusión. Se discute si en la fase lútea se puede sugerir el inicio de la abstinencia en mujeres que buscan dejar de fumar, sin embargo, las intervenciones para dejar de fumar deben tomar en cuenta todos los síntomas que se experimentan en la fase lútea.
Palabras clave:
Ciclo menstrual, síndrome premenstrual, fumar, abstinencia, revisión

Referencias

Allen, A. M., Allen, S. S., Lunos, S., & Pomerleau, C. S. (2010). Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addictive Behaviors, 35(6), 549-552. doi: 10.1016/j.addbeh.2010.01.003

Allen, A. M., Lunos, S., Heishman, S. J., al’Absi, M., Hatsukami, D., & Allen, S. S. (2015). Subjective response to nicotine by menstrual phase. Addictive Behaviors, 43, 50-53. doi: 10.1016/j.addbeh.2014.12.008

Allen, A. M., McRae-Clark, A. L., Carlson, S., Saladin, M. E., Gray, K. M., Wetherington, C. L., … Allen, S. S. (2016). Determining menstrual phase in human biobehavioral research: A review with recommendations. Experimental and Clinical Psychopharmacology, 24(1), 1-11. doi: 10.1037/pha0000057

Allen, A., Skobic, I., Bell, M. L., Medvescek, K., Allen, S., Collins, B., & Nair, U. (2022). Feasibility and acceptability of testing a menstrual-cycle timed smoking cessation intervention for women of reproductive age (Project Phase): Results of a pilot randomized control trial. Addictive Behaviors, 125, 107153. doi: 10.1016/j.addbeh.2021.107153

Allen, S. S., Allen, A. M., Kotlyar, M., Lunos, S., al’Absi, M., & Hatsukami, D. (2013). Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence. Nicotine & Tobacco Research, 15(6), 1091-1098. doi: 10.1093/ntr/nts236

Allen, S. S., Allen, A. M., Tosun, N., Lunos, S., al’Absi, M., & Hatsukami, D. (2014). Smoking-and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms. Addictive Behaviors, 39(5), 901-906. doi: 10.1016/j.addbeh.2014.01.029

al’Absi, M., Hatsukami, D., & Davis, G. L. (2005). Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology, 181(1), 107-117. doi: 10.1007/s00213-005-2225-3

Carlson, S. C., Allen, A. M., Allen, S. S., & al’Absi, M. (2017). Differences in mood and cortisol by menstrual phase during acute smoking abstinence: A within-subject comparison. Experimental and Clinical Psychopharmacology, 25(5), 338-345. doi: 10.1037/pha0000142

Carpenter, M. J., Upadhyaya, H. P., LaRowe, S. D., Saladin, M. E., & Brady, K. T. (2006). Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine & Tobacco Research, 8(5), 627-638. doi: 10.1080/14622200600910793

Castaldelli-Maia, J. M., Nesoff, E. D., Lima, D. R., Sanchez, Z. M., & Martins, S. S. (2022). The first day of smoking abstinence is more challenging for women than men: A meta-analysis and meta-regression across 12 low-and middle-income countries. Addictive Behaviors, 128, 107234. doi: 10.1016/j.addbeh.2021.107234

Castellani, V., Gonçalves, P. D., Castaldelli-Maia, J., & Malbergier, A. (2020). Investigating gender differences for effectiveness and side effects of varenicline during smoking cessation treatment. Revista da Associação Médica Brasileira, 66(2), 146-152. doi: 10.1590/1806-9282.66.2.146

Choi, S. H., & Hamidovic, A. (2020). Association between smoking and premenstrual syndrome: A Meta-Analysis. Frontiers in Psychiatry, 11, 575526. doi: 10.3389/fpsyt.2020.575526

Ditre, J. W., Zale, E. L., & Brandon, T. H. (2015). Patterns and predictors of smoking cessation. In The Tobacco Epidemic (2nd ed.). Karger Publishers.

Farris, S. G., Abrantes, A. M., & Zvolensky, M. J. (2019). Emotional distress and tobacco demand during the menstrual cycle in female smokers. Cognitive Behaviour Therapy, 48(3), 177-183. doi: 10.1080/16506073.2018.1494208

Franklin, T. R., & Allen, S. S. (2009). Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction, 104(11), 1941-1942. doi: 10.1111/j.1360-0443.2009.02758.x

Hendricks, P. S., Wood, S. B., Baker, M. R., Delucchi, K. L., & Hall, S. M. (2011). The Smoking Abstinence Questionnaire: Measurement of smokers’ abstinence‐related expectancies. Addiction, 106(4), 716-728. doi: 10.1111/j.1360-0443.2010.03338.x

Hughes, J. R. (2007). Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research, 9(3), 315-327. doi: 10.1080/14622200701188919

Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43(3), 289-294. Retrieved from https://jamanetwork.com/journals/jamapsychiatry/article-abstract/493770

Lynch, W., & Sofuoglu, M. (2010). Role of progesterone in nicotine addiction: Evidence from initiation to relapse. Experimental Clinical Psychopharmacol, 18(6), 451-461. doi: 10.1037/a0021265

McNulty, K. L., Elliott-Sale, K. J., Dolan, E., Swinton, P. A., Ansdell, P., Goodall, S., … Hicks, K. M. (2020). The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Medicine, 50(10), 1813-1827. doi: 10.1007/s40279-020-01319-3

Nakajima, M., Allen, S., & al’Absi, M. (2019). Influences of the menstrual phase on cortisol response to stress in nicotine dependent women: A preliminary examination. Nicotine and Tobacco Research, 21(5), 617-622. doi: 10.1093/ntr/nty071

Organización Mundial de la Salud. (2018). WHO global report on trends in prevalence of tobacco smoking 2000-2025 (2nd ed.). World Health Organization. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/272694/9789241514170-eng.pdf

O’Dell, L. E., & Torres, O. V. (2014). A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females. Neuropharmacology, 76, 566-580. doi: 10.1016/j.neuropharm.2013.04.055

Pang, R. D., Andrabi, N., & Leventhal, A. M. (2017). Premenstrual symptoms and factors implicated in smoking cessation among woman smokers. Experimental and Clinical Psychopharmacology, 25(4), 235-241. doi: 10.1037/pha0000132

Pang, R. D., Bello, M. S., Stone, M. D., Kirkpatrick, M. G., Huh, J., Monterosso, J., … Leventhal, A. M. (2016). Premenstrual symptoms and smoking-related expectancies. Addictive Behaviors, 57, 38-41. doi: 10.1016/j.addbeh.2016.01.015

Perkins, K. A. (2001). Smoking cessation in women. Special considerations. CNS Drugs, 15(5), 391-411. doi: 10.2165/00023210-200115050-00005

Schiller, C. E., Saladin, M. E., Gray, K. M., Hartwell, K. J., & Carpenter, M. J. (2012). Association between ovarian hormones and smoking behavior in women. Experimental and Clinical Psychopharmacology, 20(4), 251-257. doi: 10.1037/a0027759

Sieminska, A., & Jassem, E. (2014). The many faces of tobacco use among women. Medical Science Monitor, 20, 153-162. doi: 10.12659/MSM.889796

Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., ... Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. doi: 10.7326/M18-0850

Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008). Declaración de la iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales. Revista Española de Salud Pública, 82, 251-259. doi: 10.1016/j.gaceta.2008.12.001

Weinberger, A. H., Smith, P. H., Allen, S. S., Cosgrove, K. P., Saladin, M. E., Gray, K. M., Mazure, C. M., Wetherington, C. L., & McKee, S. A. (2015). Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine & Tobacco Research, 17(4), 407-421. doi: 10.1093/ntr/ntu249

Wetherill, R. R., Franklin, T. R., & Allen, S. S. (2016). Ovarian hormones, menstrual cycle phase, and smoking: a review with recommendations for future studies. Current Addiction Reports, 3(1), 1-8. doi: 10.1007/s40429-016-0093-z